Robert Connelly, Elicio Therapeutics CEO
January 17, 2023 07:21 AM EST
Deals

Can­cer vac­cine de­vel­op­er jumps to Nas­daq via re­verse merg­er

Amber Tong

An IPO was off the ta­ble, but the im­munother­a­py ex­perts at Eli­cio Ther­a­peu­tics found a way to the pub­lic mar­kets af­ter all.

Eli­cio is merg­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times